Paper

Hemp, Inc. Announces Significant Progress in Hemp Seed Meal Approval for Laying Hen Diets

Retrieved on: 
Wednesday, March 27, 2024

LAS VEGAS, NV, March 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- In a recent development for the agricultural and hemp industries, Hemp, Inc. (OTC: HEMP) is thrilled to announce that hemp seed meal is on the cusp of receiving approval for use in animal feed, starting with laying hen diets.

Key Points: 
  • LAS VEGAS, NV, March 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- In a recent development for the agricultural and hemp industries, Hemp, Inc. (OTC: HEMP) is thrilled to announce that hemp seed meal is on the cusp of receiving approval for use in animal feed, starting with laying hen diets.
  • Hemp seed meal is recognized for its rich content of vitamins, minerals, oils, and proteins, offering substantial benefits to laying hens.
  • Notably, hemp seeds are devoid of THC and CBD, components that have raised concerns in other hemp products due to potential contamination risks.
  • The Hemp Feed Coalition has ensured that any presence of these substances in hemp seed will be classified as contaminants, aligning with regulatory standards.

Canon Announces the ProStream 3160 as Flagship Model of the ProStream 3000 Series

Retrieved on: 
Tuesday, March 26, 2024

The ProStream 3160 is an ultra-fast roll-fed 4/4 inkjet press that  can deliver up to 525 feet per minute (160 meters per minute).

Key Points: 
  • The ProStream 3160 is an ultra-fast roll-fed 4/4 inkjet press that  can deliver up to 525 feet per minute (160 meters per minute).
  • This press is market changing and shows Canon’s commitment to the evolution of this ProStream 3000 platform.
  • The ProStream 3160 enables ultra-fast production, allowing print business to move high volumes of work from offset and legacy technologies.
  • To find out more about the Canon ProStream 3160, as well as the ProStream 2000 series* to be featured at drupa in Dusseldorf, Germany in May-June 2024, visit here .

LINKING SECURITY: ALLEGION US FEATURES INTEROPERABILITY, MOBILE CREDENTIALS, SCHLAGE XE360™ AND SERVICES AT ISC WEST

Retrieved on: 
Tuesday, April 9, 2024

LAS VEGAS, April 9, 2024 /PRNewswire/ -- Allegion US, a leading provider of security solutions, technology and services, will be exhibiting and demonstrating new interoperable electronic access control technologies and software at the ISC West 2024 (booth # 20055), the security industry's most comprehensive and converged trade show occurring from April 9-12, 2024, at the Venetian Expo in Las Vegas.

Key Points: 
  • Through the Allegion Alliance Network , Allegion develops collaborative relationships with other companies to provide a broader range of products and services.
  • In addition, participation with Connectivity Standards Alliance (CSA) and the FiRA consortium provides cutting-edge, cross-industry collaboration with a focus on solving for end-user needs.
  • And collaboration with leading companies like SwiftConnect provides customers with accelerated adoption of NFC access control and seamless access experiences.
  • Attendees can speak with on-the-floor experts to learn about how to help schools implement PASS Guidelines and avoid critical security mistakes.

U.S. DOE Selects Heidelberg Materials’ New Cement Plant in Mitchell, Indiana for Industrial Demonstrations Program Funding

Retrieved on: 
Monday, March 25, 2024

The purpose of this project is to advance the integration of full-scale carbon capture, transport, and storage at the new state-of-the-art cement plant in Mitchell, Indiana.

Key Points: 
  • The purpose of this project is to advance the integration of full-scale carbon capture, transport, and storage at the new state-of-the-art cement plant in Mitchell, Indiana.
  • The funding will build on prior funding that has been awarded by the DOE toward successfully completing the Front-End Engineering and Design (FEED) work necessary to verify the project’s technical feasibility.
  • The application was submitted in 2023, and Heidelberg Materials will participate in substantial cost share that will leverage up to $500M in DOE project funding.
  • “Thanks to President Biden’s industrial strategy, DOE is making the largest investment in industrial decarbonization in the history of the United States.

Technip Energies and LanzaTech Selected by the US Department of Energy to Receive $200M Investment for Breakthrough, Replicable Decarbonized Ethylene Commercial Facility

Retrieved on: 
Monday, March 25, 2024

This new joint technology will be developed in the U.S. for integration directly into existing commercial ethylene crackers, whereby it will capture CO2 emissions from the process and convert them into sustainable ethylene.

Key Points: 
  • This new joint technology will be developed in the U.S. for integration directly into existing commercial ethylene crackers, whereby it will capture CO2 emissions from the process and convert them into sustainable ethylene.
  • Arnaud Pieton, CEO at Technip Energies, stated: “We are extremely proud to have been selected by the DOE for this significant award consideration.
  • Thanks to President Biden’s industrial strategy, DOE is making the largest investment in industrial decarbonization in the history of the United States.
  • Globally, there are an estimated 370 ethylene steam crackers, over 40% of which use Technip Energies’ technology, including 8 in the US.

At the Yacht Club de Monaco the inauguration ceremony of the first Explorer Dock

Retrieved on: 
Thursday, March 21, 2024

At the Yacht Club de Monaco the inauguration ceremony of the first Explorer Dock took place, as part of the activities planned for the Ocean Week and under the aegis of the collective ‘Monaco, Capital of Advanced Yachting’ approach.

Key Points: 
  • At the Yacht Club de Monaco the inauguration ceremony of the first Explorer Dock took place, as part of the activities planned for the Ocean Week and under the aegis of the collective ‘Monaco, Capital of Advanced Yachting’ approach.
  • “I am very humbled and proud to be here because it took years to build this yacht.
  • And now to see it here surrounded by the Yacht Club it just makes your skin tingle,” said Greg Marshall.
  • Organised in partnership with the Prince Albert II of Monaco Foundation and YCM, it is a natural extension of the Monaco Smart & Sustainable Marina Rendezvous.

NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine

Retrieved on: 
Thursday, March 21, 2024

NMD Pharma’s lead development candidate, NMD670, a novel, selective, and orally bioavailable ClC-1 inhibiting small molecule, is used in the preclinical and clinical studies.

Key Points: 
  • NMD Pharma’s lead development candidate, NMD670, a novel, selective, and orally bioavailable ClC-1 inhibiting small molecule, is used in the preclinical and clinical studies.
  • NMD670 is a muscle-targeted therapy which aims to enhance the activation of skeletal muscle fibers and to improve muscle strength and endurance.
  • As a result, patients have impaired skeletal muscle function and often experience severe muscle weakness and fatigue.
  • Access the full paper in Science Translational Medicine online here:
    In October 2022, NMD Pharma announced positive topline data which established the first clinical proof-of-mechanism of NMD Pharma’s novel CIC-1 chloride channel inhibitor approach in patients impacted by MG.

NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine

Retrieved on: 
Thursday, March 21, 2024

NMD Pharma’s lead development candidate, NMD670, a novel, selective, and orally bioavailable ClC-1 inhibiting small molecule, is used in the preclinical and clinical studies.

Key Points: 
  • NMD Pharma’s lead development candidate, NMD670, a novel, selective, and orally bioavailable ClC-1 inhibiting small molecule, is used in the preclinical and clinical studies.
  • NMD670 is a muscle-targeted therapy which aims to enhance the activation of skeletal muscle fibers and to improve muscle strength and endurance.
  • As a result, patients have impaired skeletal muscle function and often experience severe muscle weakness and fatigue.
  • Access the full paper in Science Translational Medicine online here:
    In October 2022, NMD Pharma announced positive topline data which established the first clinical proof-of-mechanism of NMD Pharma’s novel CIC-1 chloride channel inhibitor approach in patients impacted by MG.

DVCon U.S. 2024 Announces Stuart Sutherland Best Paper & Best Poster Winners & Conference Highlights

Retrieved on: 
Tuesday, March 19, 2024

The 2024 Best Paper and Poster winners, as voted on by attendees, were announced during a reception in the exhibit hall on March 6.

Key Points: 
  • The 2024 Best Paper and Poster winners, as voted on by attendees, were announced during a reception in the exhibit hall on March 6.
  • Overall attendance for DVCon U.S. 2024 was approximately 975, including attendees from 25 exhibiting companies.
  • “It was really an exciting time to be back at DVCon U.S.,” stated Tom Fitzpatrick, DVCon U.S. 2024 General Chair.
  • For the second consecutive year, the Poster Ninja Warrior Session determined the Stuart Sutherland Best Poster Award winners.

EFI Expands Portfolio of Innovation for Sign and Display Graphics at FESPA with New VUTEk Q3h XP and EFI Pro 33r Printers

Retrieved on: 
Tuesday, March 19, 2024

“With a comprehensive portfolio of production printers with the most advanced technology and innovative inks and coatings for the sign and display.

Key Points: 
  • “With a comprehensive portfolio of production printers with the most advanced technology and innovative inks and coatings for the sign and display.
  • The new, 3.3-metre-wide VUTEk Q3h XP hybrid flatbed/roll-fed LED printer, making its worldwide debut, is designed to provide high-quality imaging and production-level printing for faster turnarounds.
  • The printer is available with four (CMYK) or six (CMYK, lc, lk) colours and optional white and clear inks.
  • EFI is also exhibiting the 3.5-metre-wide EFI VUTEk Q3r roll-to-roll LED printer that provides a complete print-to-finished graphic workflow, from RIP to finished product.